4.6 Article

Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression

Related references

Note: Only part of the references are listed.
Article Oncology

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma

Salvador Alejo et al.

Summary: In this study, the role of KDM1A/LSD1 in DNA double-strand break (DSB) repair and the combination of KDM1A inhibitor and temozolomide (TMZ) were investigated in glioblastoma. The results showed that inhibition of KDM1A enhances TMZ efficacy, reduces the viability and self-renewal of tumor cells, attenuates DNA repair pathways, and enhances TMZ-mediated DNA damage.

NEURO-ONCOLOGY (2023)

Article Oncology

Reticulocalbin3: A Ca2+ homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance

Rui Cai et al.

Summary: This study identifies reticulocalbin3 (RCN3) as a regulator of calcium homeostasis in esophageal squamous cell carcinoma (ESCC), promoting tumor progression and platinum resistance. RCN3 could serve as a predictive factor of poor prognosis and potential therapeutic target in ESCC patients.

CANCER SCIENCE (2022)

Article Oncology

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019

Quinn T. Ostrom et al.

Summary: The report provides the latest data on primary brain tumors in the United States, including incidence rates, mortality rates, and relative survival rates. The overall incidence rate is higher in females and non-Hispanic population, and glioblastoma is the most common malignant brain tumor, while meningioma is the most common non-malignant brain tumor. The relative survival rate is lower for malignant brain tumors and higher for non-malignant brain tumors.

NEURO-ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Deregulation of ribosomal proteins in human cancers

Wendy El Khoury et al.

Summary: The ribosome, composed of rRNAs and RPs, is the site for protein synthesis. RPs have been shown to play roles in various pathological processes, especially tumorigenesis and cell transformation. This review focuses on recent advances in understanding the effects of RPs deregulation in different types of cancer and their roles in regulating tumor cell fate.

BIOSCIENCE REPORTS (2021)

Article Respiratory System

Rcn3 Suppression Was Responsible for Partial Relief of Emphysema as Shown by Specific Type II Alveolar Epithelial Cell Rcn3 CKO Mouse Model

Qianyu Zhang et al.

Summary: Increased expression of Rcn3 in lung tissues is associated with emphysema severity in COPD patients, and this effect is also observed in mouse models of emphysema. Selective deletion of Rcn3 in AECIIs can alleviate the severity of emphysema in response to induced injury in mice.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2021)

Article Physiology

Reticulocalbin 3 deficiency in alveolar epithelium attenuated LPS-induced ALI via NF-κB signaling

Xiaoqian Shi et al.

Summary: The study reveals a significant induction of Rcn3 in alveolar epithelium during ALI, with Rcn3 playing a crucial role in regulating the alveolar inflammatory response to pulmonary infection through the NF-kappa B/NLRP3/inflammasome axis. Selective deletion of Rcn3 in alveolar epithelial cells attenuated ALI and alveolar inflammation induced by LPS, shedding light on the potential mechanism for ARDS/ALI.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Review Biotechnology & Applied Microbiology

Strategies for delivering therapeutics across the blood-brain barrier

Georg C. Terstappen et al.

Summary: The blood-brain barrier presents a challenge for delivering therapeutics to the central nervous system, particularly for biopharmaceuticals. Non-invasive approaches have been developed to help overcome this challenge, with increasing research efforts focusing on technologies to deliver therapeutics to the CNS, some of which have entered clinical testing. Developing effective strategies for crossing the blood-brain barrier is crucial for treating CNS disorders, with a particular emphasis on non-invasive methods such as receptor-mediated transcytosis and the use of neurotropic viruses, nanoparticles, and exosomes.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Multidisciplinary Sciences

Reticulocalbin 3 is involved in postnatal tendon development by regulating collagen fibrillogenesis and cellular maturation

Na Rae Park et al.

Summary: The study found that Rcn3 plays a critical regulatory role in tendon development, with its deficiency leading to abnormalities in collagen fibrillogenesis and tenocyte maturation, ultimately affecting the mechanical properties of tendons.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis

Richard Y. Ebright et al.

SCIENCE (2020)

Review Cell Biology

Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer

Ryan C. Gimple et al.

GENES & DEVELOPMENT (2019)

Article Biochemistry & Molecular Biology

Reticulocalbin 3 Deficiency in Alveolar Epithelium Exacerbated Bleomycin-induced Pulmonary Fibrosis

Jiawei Jin et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)

Review Clinical Neurology

Multidimensional communication in the microenvirons of glioblastoma

Marike L. Broekman et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Biochemistry & Molecular Biology

Neonatal Respiratory Failure with Retarded Perinatal Lung Maturation in Mice Caused by Reticulocalbin 3 Disruption

Jiawei Jin et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)

Review Pathology

Gliomas Genomics and Epigenomics: Arriving at the Start and Knowing It for the First Time

Mariella G. Filbin et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

Review Pathology

Molecular and Genomic Alterations in Glioblastoma Multiforme

Ines Crespo et al.

AMERICAN JOURNAL OF PATHOLOGY (2015)

Review Cell Biology

Cancer stem cells in glioblastoma

Justin D. Lathia et al.

GENES & DEVELOPMENT (2015)

Article Multidisciplinary Sciences

Brain tumour cells interconnect to a functional and resistant network

Matthias Osswald et al.

NATURE (2015)

Review Cell Biology

Ribosomal proteins: functions beyond the ribosome

Xiang Zhou et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2015)

Article Multidisciplinary Sciences

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Anoop P. Patel et al.

SCIENCE (2014)

Article Multidisciplinary Sciences

A restricted cell population propagates glioblastoma growth after chemotherapy

Jian Chen et al.

NATURE (2012)

Article Oncology

Comparative proteomics analysis of human osteosarcomas and benign tumor of bone

Y. Li et al.

CANCER GENETICS AND CYTOGENETICS (2010)

Article Biochemistry & Molecular Biology

Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma

Gentao Liu et al.

MOLECULAR CANCER (2006)

Review Oncology

Brain tumour stem cells

Angelo L. Vescovi et al.

NATURE REVIEWS CANCER (2006)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)